PROCYSBI 75 mg, gastro-resistant capsule 250 capsules
Active ingredients: Cysteamine bitartrate, Cysteamine
Commercialized according to BDPMDispensing in France: Prescription only
Gastro-resistant capsule250 capsulesorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PROCYSBI 75 mg, gélule gastro-résistante
- Pharmaceutical form
- gélule gastro-résistant(e)
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 250 gélule(s)
- Marketing authorisation holder
- CHIESI FARMACEUTICI
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 30 Jun 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69022853CIP72766172CIP133400927661723Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BITARTRATE DE MERCAPTAMINEgélule | 221,10 mg · une gélule | SA |
| MERCAPTAMINEgélule | 75 mg · une gélule | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.